Peer Review History
| Original SubmissionNovember 12, 2021 |
|---|
|
PONE-D-21-33749 SEASONAL CHANGES IN INCIDENCE OF PATIENTS WITH DIABETES UNDERGOING CARDIAC SURGERY PLOS ONE Dear Dr. Petak, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 09 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chengming Fan, MD, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please amend your current ethics statement to address the following concerns: a) Did participants provide their written or verbal informed consent to participate in this study? b) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following financial disclosure: “NO” Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in the Funding Section of your manuscript: “This research was supported by a Hungarian Basic Research Council Grant (OTKA-NKFIH K138032) and a GINOP-2.3.2-15-2016-00006 grant.” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “NO” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. Thank you for stating the following in your Competing Interests section: “NO” Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 7. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option. Additional Editor Comments: Please response to the reviewers point by point. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The author indicated the seasonal chaneges in the incidence of cardiac surgery in the patients with diabetes, smoking and/or aging. One of the main findings of the study was a significant elevation of the incidence of patients with diabetes during the coldest months of the year. They speculated the mechanism using several references, and indicated the possible concerning about high blood pressure and triglyceride. The authors state that there was no seasonal change due to the difference in heart surgery, but isn't there seasonality in the amount of heart surgery? That point should be stated. The authors should state what they should be especially careful about when conducting seasonal examinations for DMs, smokers, and the elderly. Reviewer #2: As stated in the title and elsewhere in the manuscript the goal of the authors was to analyze the seasonal variation in the incidence of patients with diabetes undergoing cardiac surgery. I have several comments to make about this manuscript but the major one is about the definition the authors provide for incidence rate (methods page 6): “ incidence rates were calculated as the number of patients with a given risk factor … divided by the total number of patients in the same month.” The authors use diabetes, advanced age and smoking as outcomes and consider the entire population of hospitalized patients in a given month as the population exposed, the population at risk of developing such outcomes. This is plainly wrong. A more precise description of the authors’ work is a description of seasonal changes in the distribution of risk factors. Only percentages are provided therefore we do not know if the actual number of patients, those with DM for example, increases or decreases in a given month. Second, the authors provide only p values both in the abstract and the results. As if p values were the only numerical measure worth reporting. An actual numerical measure should be provided for each one of the results, not just their p values. Methods are insufficiently described. For example the last sentence in the abstract method section belong to the discussion. The authors should clarify the regression methods they used and the results they are referring to. Please clarify exclusion criteria both in the flow chart and the methods. Please explain the following sentence in Methods: “Since patient records were discarded in case of emergency reoperations as a consequence of tamponade or acute bleeding, patients were included in the analyses only after a primary or redo open heart surgeries”. “Since there was no difference in cardiovascular status between T2DM patients treated with insulin or oral antidiabetics…” How was this assessed? Results: “In accordance with the diagnostic criteria, HbA1c was significantly higher in patients with diabetes…” This is not a result. Since higher A1c was used to define patients with DM, by definition it is going to be higher in these patients. Why the group None from the flow chart was not included in the figures. I am unclear about which results were achieved from regression vs. stratification. Reviewer #3: Thank you for inviting me to review this manuscript. This study aims to determine seasonal trends of aging, diabetes, and smoking in a representative sample size from a single center in Hungary. The results showed higher incidence of non-elderly patients with diabetes and smoking during winter periods, while elderly population was predominant in summer periods. This study is interesting and novel, however there are several methodological flaws that reduces its utility in clinical practice. Although personally I am not convinced that season influences the volume of perioperative comorbidities, this study might elucidate further ideas/research in this area. Below I have made some comments that would improve the quality of the manuscript. Major comments (1) Abstract: Primary objective should be explicitly written in the abstract and introduction. Please mention what your primary outcome was? I am confused with this statement “Potential additive or subtractive effects of the coexistence of these factors” please re-write and clarify what effects were measured. Authors should provide more details in methods: what statistical technique did they use to measure seasonal effect? Authors should give more than p values.. what effect size did they use? (2) Introduction: authors should specify the rationale of this study. What is the primary intention of discovering seasonal changes of commorbidities among cardiac surgery patients? (3) Statistical analysis: the description is incomplete and inconsistent. Please explain how did you measure “significant seasonal change” and “season variability”, provide the effect size that you used, and what method was used to estimate P values. All this information should be clearly stated in the manuscript. Be aware that P values do not give a complete picture and have several limitations. Additionally, the authors did not explain what technique was used for the charts (figures - modeling). (4) The authors mentioned “goodness of fit” method in results, but there is no explanation of this in methods. (5) Several limitations should be discussed more broadly in the discussion. For instance, the lack of adjustment for socioeconomic factors, national policies, and institutional scheduling policies. (6) The seasonal changes of systolic/diastolic pressures in diabetic patients and smokers is interesting and should be described in more detail. I would encourage the authors to present these results in a separate paragraph “Subgroup Analysis”. (7) Discussion: “This opposite trend in mortality may be attributed to compromised elasticity” Authors did NOT present any data of mortality in this manuscript. Please be consistent. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-33749R1SEASONAL CHANGES IN INCIDENCE OF PATIENTS WITH DIABETES UNDERGOING CARDIAC SURGERYPLOS ONE Dear Dr. Petak, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 19 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chengming Fan, MD, PhD Academic Editor PLOS ONE Additional Editor Comments: Please response to the reviewers' comments point by point. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The author indicated the seasonal changes in the incidence of cardiac surgery in the patients with diabetes, smoking and/or aging. One of the main findings of the study was a significant elevation of the incidence of patients with diabetes during the coldest months of the year. They speculated the mechanism using several references, and indicated the possible concerning about high blood pressure and triglyceride. The authors are well responding to the reviewer's questions and comments. The manuscript is well revised and suitable for the publication. Reviewer #2: The authors have greatly improved the manuscript. However an important point in my opinion was not addressed. I appreciate the fact that only new surgeries were taken into account was highlighted and the sensitivity analysis using different base populations, with and w/o the risk factors, but I believe that what the authors describe is not incidence. The denominator for the incidence is the population exposed to the risk of an event. If the event is cardiac surgery and the exposure is type 2 diabetes or smoking, then the population exposed would be all people with diabetes or all smokers. Certainly not all people undergoing cardiac surgery. If the authors consider as the event “a person having diabetes AND undergoing cardiac surgery” then the population at risk would be all people with cardiac disease, with and w/o diabetes. Even if we make several reasonable assumptions: the need for cardiac surgeries among people without diabetes remains constant; the number of people at risk, with DM or smokers remain constant throughout the change of season, it is unclear why the authors present their results as incidence variations. For example, if among 100 people undergoing cardiac surgeries in one month there are 30 with diabetes, and the following month the number of people with diabetes who have surgery doubles because of temperature variation, then we would have a proportion of surgeries associated with diabetes, given the above assumptions, from 30% to 46% which is not the measure of incidence variation. Reviewer #3: Thank you for addressing most of the reviewers' comments. However, the explanation about the effect size still remains unclear. I understand that the percentage of change (variation) is the main effect size for the association between seasonal variation and health parameters. Is that right? Please be more concise and explicit in this regard. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
SEASONAL CHANGES IN PROPORTION OF CARDIAC SURGERIES ASOCIATED WITH DIABETES, SMOKING AND ELDERLY AGE PONE-D-21-33749R2 Dear Dr. Petak, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chengming Fan, MD, PhD Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: I Don't Know Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: All my comments have been addressed satisfactorily by the authors. I have no further recommendations. Reviewer #3: Thank you for addressing all my comments. This study highlights the importance of seasonal changes of comorbidities. Congratulation on a nice paper. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-21-33749R2 SEASONAL CHANGES IN PROPORTION OF CARDIAC SURGERIES ASOCIATED WITH DIABETES, SMOKING AND ELDERLY AGE Dear Dr. Petak: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Chengming Fan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .